CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME - USD ($)	3 Months Ended		6 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Net revenues	$ 11,369,607	$ 11,665,294	$ 21,573,734	$ 15,759,780
Costs and expenses
Cost of services	8,264,189	6,161,645	15,832,057	9,421,484
General and administrative	3,440,641	3,451,907	7,677,846	5,461,239
Depreciation and amortization	77,684	193,281	141,435	205,180
Total costs and expenses	11,782,514	9,806,833	23,651,338	15,087,903
(Loss) income from operations	(412,907)	1,858,461	(2,077,604)	671,877
Other (expense) income
Interest expense	(68,818)	(329,258)	(429,220)	(606,125)
Gain (loss) on change in fair value of warrant and conversion feature liabilities	96,852	152,140	(116,866)	122,135
Other	(95,092)	(58,436)	5,912	(60,912)
Total other expense	(67,058)	(235,554)	(540,174)	(544,902)
(Loss) income before provision for income taxes	(479,965)	1,622,907	(2,617,778)	126,975
Income tax (benefit) provision	(186,138)	86,989	(93,447)	98,591
Net (loss) income	(293,827)	1,535,918	(2,524,331)	28,384
Net income attributable to non-controlling interest	(237,539)	(159,608)	(489,401)	(329,815)
Net (loss) income attributable to Apollo Medical Holdings, Inc.	(531,366)	1,376,310	(3,013,732)	(301,431)
Other comprehensive gain:
Unrealized gain on change in value of marketable securities	0	14,499	0	33,088
Comprehensive (loss) income	$ (531,366)	$ 1,390,809	$ (3,013,732)	$ (268,343)
NET LOSS PER SHARE:
BASIC	$ (0.11)	$ 0.28	$ (0.62)	$ (0.06)
DILUTED	$ (0.11)	$ 0.26	$ (0.62)	$ (0.06)
WEIGHTED AVERAGE SHARES OF COMMON STOCK OUTSTANDING:
BASIC	4,863,389	4,913,455	4,863,389	4,913,455
DILUTED	4,863,389	5,439,344	4,863,389	4,913,455